Penile Rehabilitation Therapy with PDE-V Inhibitors Following Radical Prostatectomy: Proceed with Caution
Author(s) -
M. Eric Brewer,
Edward D. Kim
Publication year - 2009
Publication title -
advances in urology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.18
H-Index - 30
eISSN - 1687-6377
pISSN - 1687-6369
DOI - 10.1155/2009/852437
Subject(s) - medicine , prostatectomy , urology , penis , erectile dysfunction , rehabilitation , atrophy , erectile function , surgery , physical therapy , prostate , cancer
Penile rehabilitation therapy following radical prostatectomy is a much debated topic. Erectile dysfunction is still a significant contributor to postoperative morbidity following radical prostatectomy, despite meticulous nerve-sparing technique. Secondary smooth muscle changes in the penis have been identified as the underlying causes of penile atrophy, veno-occlusive dysfunction, and fibrosis. Initial observations that intracavernous injection therapies used on a regular basis postoperatively resulted in improvements in the return of spontaneous erectile function led to the development of penile rehabilitation protocols. Chronic dosing of PDE-V inhibitors is now commonly used by urologists after radical prostatectomy. Despite the current enthusiasm of penile rehabilitation therapy, current scientific evidence with clinical trials is still limited.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom